PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IQV vs. IDXX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IQV and IDXX is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

IQV vs. IDXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IQVIA Holdings Inc. (IQV) and IDEXX Laboratories, Inc. (IDXX). The values are adjusted to include any dividend payments, if applicable.

-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-12.75%
-9.54%
IQV
IDXX

Key characteristics

Sharpe Ratio

IQV:

-0.09

IDXX:

-0.66

Sortino Ratio

IQV:

0.08

IDXX:

-0.82

Omega Ratio

IQV:

1.01

IDXX:

0.90

Calmar Ratio

IQV:

-0.09

IDXX:

-0.42

Martin Ratio

IQV:

-0.20

IDXX:

-1.02

Ulcer Index

IQV:

13.93%

IDXX:

17.51%

Daily Std Dev

IQV:

30.05%

IDXX:

27.11%

Max Drawdown

IQV:

-49.43%

IDXX:

-81.46%

Current Drawdown

IQV:

-26.75%

IDXX:

-39.42%

Fundamentals

Market Cap

IQV:

$37.57B

IDXX:

$35.01B

EPS

IQV:

$7.60

IDXX:

$10.36

PE Ratio

IQV:

27.24

IDXX:

41.27

PEG Ratio

IQV:

1.08

IDXX:

4.58

Total Revenue (TTM)

IQV:

$11.45B

IDXX:

$2.94B

Gross Profit (TTM)

IQV:

$3.47B

IDXX:

$1.81B

EBITDA (TTM)

IQV:

$2.38B

IDXX:

$977.28M

Returns By Period

In the year-to-date period, IQV achieves a 5.34% return, which is significantly higher than IDXX's 3.41% return. Over the past 10 years, IQV has underperformed IDXX with an annualized return of 13.13%, while IDXX has yielded a comparatively higher 18.43% annualized return.


IQV

YTD

5.34%

1M

3.82%

6M

-12.75%

1Y

-4.21%

5Y*

5.51%

10Y*

13.13%

IDXX

YTD

3.41%

1M

3.03%

6M

-9.54%

1Y

-18.56%

5Y*

8.81%

10Y*

18.43%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IQV vs. IDXX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IQV
The Risk-Adjusted Performance Rank of IQV is 3838
Overall Rank
The Sharpe Ratio Rank of IQV is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of IQV is 3434
Sortino Ratio Rank
The Omega Ratio Rank of IQV is 3434
Omega Ratio Rank
The Calmar Ratio Rank of IQV is 4040
Calmar Ratio Rank
The Martin Ratio Rank of IQV is 4141
Martin Ratio Rank

IDXX
The Risk-Adjusted Performance Rank of IDXX is 1616
Overall Rank
The Sharpe Ratio Rank of IDXX is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 1313
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 1414
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 2020
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 2121
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IQV vs. IDXX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IQVIA Holdings Inc. (IQV) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IQV, currently valued at -0.09, compared to the broader market-2.000.002.00-0.09-0.66
The chart of Sortino ratio for IQV, currently valued at 0.08, compared to the broader market-4.00-2.000.002.004.000.08-0.82
The chart of Omega ratio for IQV, currently valued at 1.01, compared to the broader market0.501.001.502.001.010.90
The chart of Calmar ratio for IQV, currently valued at -0.09, compared to the broader market0.002.004.006.00-0.09-0.42
The chart of Martin ratio for IQV, currently valued at -0.20, compared to the broader market-10.000.0010.0020.00-0.20-1.02
IQV
IDXX

The current IQV Sharpe Ratio is -0.09, which is higher than the IDXX Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of IQV and IDXX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.09
-0.66
IQV
IDXX

Dividends

IQV vs. IDXX - Dividend Comparison

Neither IQV nor IDXX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IQV vs. IDXX - Drawdown Comparison

The maximum IQV drawdown since its inception was -49.43%, smaller than the maximum IDXX drawdown of -81.46%. Use the drawdown chart below to compare losses from any high point for IQV and IDXX. For additional features, visit the drawdowns tool.


-45.00%-40.00%-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-26.75%
-39.42%
IQV
IDXX

Volatility

IQV vs. IDXX - Volatility Comparison

The current volatility for IQVIA Holdings Inc. (IQV) is 6.47%, while IDEXX Laboratories, Inc. (IDXX) has a volatility of 6.94%. This indicates that IQV experiences smaller price fluctuations and is considered to be less risky than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
6.47%
6.94%
IQV
IDXX

Financials

IQV vs. IDXX - Financials Comparison

This section allows you to compare key financial metrics between IQVIA Holdings Inc. and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab